A U.K. marketing watchdog has sanctioned Sanofi after ruling its CEO Paul Hudson may have undermined the U.K. government’s ...
During the first six months of Maziar Mike Doustdar's tenure as Novo Nordisk's CEO, the company enjoyed a run of positive ...
Ahead of the readouts, BMS and J&J have started an educational push called “Change the Target. Change What’s Possible,” they ...
Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its ...
AstraZeneca has hit what appears to be a minor speed bump in gaining clearance in the U.S. for its subcutaneous (SC) version of lupus treatment Saphnelo. | AstraZeneca will have to negotiate what ...
Over the last decade-plus, China has become a booming biopharma innovator thanks in part to a big boost from its government. Now the question is, can its neighbor to the south, India, make a similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results